Prominent Attorney with Terminal Cancer Gets Tysabri After Biogen Idec’s Earlier Denial- Its Implications for Prostate Cancer Treatment

A prominent attorney, Frederick Baron, who is dying of bone marrow cancer, has been granted his wish, to receive the drug Tysabri. After significant wrangling, The FDA and the Mayo Clinic found a legal basis to give him the drug in an emergency situation, even though Tysabri is not approved for any cancers. This decision [...]